Position in CGON
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,537,750
-$24,152 QoQ
Shares Held
63,867
-5.2% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#77
of 226 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CGON Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PICTON MAHONEY ASSET MANAGEMENT holds $70,922,376 across 23 Biotechnology names. CGON ranks #7 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
165,000 | $21,900,450 | |
| 2 | QURE |
uniQure N.V.
|
181,215 | $8,346,762 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
65,880 | $7,314,656 | |
| 4 | ZYME |
Zymeworks Inc.
|
271,343 | $7,092,906 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
47,679 | $5,581,780 | |
| 6 | CAI |
Caris Life Sciences, Inc.
|
264,064 | $4,705,620 | |
| 7 | CGON |
CG Oncology, Inc.
This page
|
63,867 | $4,537,750 | |
| 8 | ABVX |
Abivax S.A.
|
27,712 | $3,692,901 |
All Filings in CGON
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,537,750 | 63,867 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,561,902 | 67,404 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $118,332 | 2,850 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||